Aurora Cannabis Inc. (ACB)
| Market Cap | 297.83M +22.2% |
| Revenue (ttm) | 221.16M +12.3% |
| Net Income | -84.59M |
| EPS | -1.45 |
| Shares Out | 64.86M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 830,259 |
| Open | 4.590 |
| Previous Close | 4.610 |
| Day's Range | 4.490 - 4.615 |
| 52-Week Range | 2.560 - 6.360 |
| Beta | 1.50 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 5, 2026 |
About ACB
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient ... [Read more]
News
Why Didn't Tilray Brands Make a Bid for Aurora Cannabis?
Multiple companies have made offers for Aurora's business this year, but Tilray hasn't shown any interest.
Curaleaf granted all competition law clearances for Aurora Cannabis acquisition
Curaleaf (CURLF) has received competition law clearances in Germany and Canada for its proposed acquisition of Aurora Cannabis (ACB). Germany and Canada are the only jurisdictions in which competition...
The Big Winner From the Aurora Cannabis-Organigram Deal: Curaleaf
Organigram is valuing Aurora Cannabis more highly than Curleaf, but that doesn't mean it's the best option for shareholders in the long run.
Aurora Cannabis Announces Fiscal 2027 Second Quarter Results and Organigram Acquisition Agreement
Aurora Cannabis Inc. announced its financial results for the second quarter 2027 ending September 30, 2026, and disclosed that it has entered into a definitive agreement with Organigram Global Inc. un...
Aurora Cannabis MD&A: Q2 2027
Aurora Cannabis filed a regulatory document on November 5, 2026 disclosing important business information.
Aurora Cannabis Report: Q2 2027
Aurora Cannabis published a report on November 5, 2026 containing material business information for investors and shareholders.
Aurora Cannabis Earnings release: Q2 2027
Aurora Cannabis released its Q2 2027 earnings on November 5, 2026, summarizing the period's financial results.
Aurora Cannabis Earnings release: Q2 2027
Aurora Cannabis released its Q2 2027 earnings on November 5, 2026, summarizing the period's financial results.
Aurora Cannabis reports Q2 revenue C$86.021M vs C$78.8M last year
Announces C$133.0M of cash, cash equivalents and short-term investments with no debt
Aurora Cannabis Announces Fiscal 2027 Second Quarter Results
EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ | TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and oper...
Aurora Cannabis Inc. Enters into Arrangement Agreement to be Acquired by Organigram Global Inc. for C$7.80 Per Share
Aurora Cannabis Inc. entered into an arrangement agreement dated November 2, 2026, with Organigram Global Inc., under which Organigram will acquire all issued and outstanding common shares of Aurora. ...
Curaleaf Issues Statement Regarding Alternative Proposal for Aurora Cannabis
STAMFORD, Conn., Nov. 3, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf"), a leading international provider of consumer and medical cannabis products, today acknowl...
Organigram to Acquire Aurora Cannabis Inc. for C$7.80 Per Share
Aurora Cannabis Inc. has entered into an arrangement agreement with Organigram Global Inc. under which Organigram will acquire all of the issued and outstanding common shares of Aurora for C$7.80 per ...
Organigram signs friendly deal to buy Edmonton-based Aurora Cannabis after hostile Curaleaf offer
Organigram CEO James Yamanaka says the transaction is a defining step in the company's strategy to build a disciplined, global cannabis leader.
Aurora Cannabis downgraded to Sell from Buy at TD Securities
TD Securities downgraded Aurora Cannabis (ACB) to Sell from Buy with a C$7.80 price target after the company entered into an agreement pursuant to which Organigram will acquire all the…
Organigram To Acquire Aurora Cannabis In C$561 Mln Deal
(RTTNews) - Organigram Global Inc. (OGI) and Aurora Cannabis Inc. (ACB) have entered into an arrangement agreement under which Organigram will acquire all outstanding Aurora shares for C$7.80 apiece, ...
Aurora Cannabis trading resumes
09:50 EST Aurora Cannabis (ACB) trading resumes
Organigram to acquire Aurora Cannabis for C$7.80 per share
Organigram Global (OGI) and Aurora Cannabis (ACB) announced that they have entered into an arrangement agreement pursuant to which Organigram will acquire all of the issued and outstanding common shar...
Organigram to acquire Aurora Cannabis for C$7.80 per share
09:17 EST Organigram (OGI) to acquire Aurora Cannabis (ACB) for C$7.80 per share
Organigram to Acquire Aurora and Establish a Global Cannabis Leader
TORONTO & EDMONTON, Alberta--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (“Organigram”) and Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) (“Aurora”) today announced that they have...
Aurora Cannabis trading halted, news pending
08:25 EST Aurora Cannabis (ACB) trading halted, news pending
Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call
EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it will ...
Curaleaf Holdings, Inc. Responds to Alberta Securities Commission Decision Regarding Aurora Cannabis
Curaleaf Holdings, Inc. issued a statement on October 27, 2026, in response to the Alberta Securities Commission ruling regarding Aurora Cannabis Inc.'s at-the-market program. Boris Jordan, Chairman o...
Curaleaf responds to Alberta Securities Commission’s ruling on ATM program
Curaleaf Holdings (CURLF) issued the following statement in response to the Alberta Securities Commission’s ruling regarding Aurora Cannabis’ (ACB) at-the-market program. “Aurora would like shareholde...
Aurora Cannabis Announces Alberta Securities Commission Dismissal of Curaleaf Application on October 26, 2026
Aurora Cannabis Inc. announced that the Alberta Securities Commission has dismissed an application by Curaleaf Holdings, Inc. to halt Aurora's at-the-market program. The company stated that this decis...